- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This applied clinical medicine and public health text introduces the fundamental concepts in epidemiological investigation and demonstrates how to integrate emerging research on epigenomics into practice.
Andere Kunden interessierten sich auch für
- Rafal BurdzikEpidemic Risk Analysis and Assessment in Transport Services219,99 €
- Mark A MentzerApplied Optics Fundamentals and Device Applications262,99 €
- Poh-Chin LaiSpatial Epidemiological Approaches in Disease Mapping and Analysis157,99 €
- Lee W. RileyMolecular Epidemiology of Infectious Diseases: Principles and Practices104,99 €
- Gavin ShaddickSpatio-Temporal Methods in Environmental Epidemiology with R130,99 €
- Gunther F. Craun / Evelyn Talbott (eds.)An Introduction to Environmental Epidemiology241,99 €
- Jos W. R. TwiskApplied Longitudinal Data Analysis for Epidemiology: A Practical Guide126,99 €
-
-
-
This applied clinical medicine and public health text introduces the fundamental concepts in epidemiological investigation and demonstrates how to integrate emerging research on epigenomics into practice.
Produktdetails
- Produktdetails
- Verlag: Routledge
- Seitenzahl: 314
- Erscheinungstermin: 1. Dezember 2023
- Englisch
- Abmessung: 233mm x 156mm x 21mm
- Gewicht: 1039g
- ISBN-13: 9780367556426
- ISBN-10: 0367556421
- Artikelnr.: 68712890
- Verlag: Routledge
- Seitenzahl: 314
- Erscheinungstermin: 1. Dezember 2023
- Englisch
- Abmessung: 233mm x 156mm x 21mm
- Gewicht: 1039g
- ISBN-13: 9780367556426
- ISBN-10: 0367556421
- Artikelnr.: 68712890
Laurens Holmes, Jr. is a specialist in Immunology and Infectious Disease as well as an expert in cancer epidemiology and biostatistical modeling. He is a major proponent of aberrant epigenomic modulations in disease incidence, morbidity, prognosis, mortality and survival; and a former Head of the Epidemiology Laboratory at the Nemours Center for Childhood Cancer Research, Wilmington; former clinical and translational science education and training director, Medical College of Wisconsin, Milwaukee; as well as a former Professor of Molecular Epidemiology and Clinical Trials at the University of Delaware, USA. Professor Holmes is currently the Director of the Graduate Public Health Program at Delaware State University, Dover, USA.
Part 1: Epidemiology and Epigenomic Epidemiology Contribution in Clinical
Medicine and Public Health. 1.Introductory Epigenomic Epidemiology: Basic
Concepts and Application. 2.Public Health, Epidemiology and Translational
Epigenomic Epidemiology Perspective. 3.Scientific Research Concept and
Application: Public Health, Clinical Medicine and Epigenomic Epidemiology
Studies. 4.Disease Ascertainment-Diagnostic and Screening Test.
5.Epigenomic Epidemiology: Disease Association, Etiology, Prognosis and
Outcomes. Part 2 Traditional and Modern Epidemiologic Designs 6.Measures of
Disease Occurrence and Effect or Association. 7.Ecologic Design.
8.Cross-Sectional Study Design (Non-experimental). 9.Case-Control
(Comparison/Non-Case) Design. 10.Cohort Designs: Prospective,
Retrospective, Ambi-directional. 11.Human Experimental Design-Clinical
Trials. 12.Epidemiologic Causal Inference: Causality Web, Meta-Analysis,
Quantitative Evidence Synthesis (QES). Part 3 Laboratory Techniques and
Epigenomic Mechanistic Process in Epidemiologic Principles, Concept and
Application. 13.Epigenomic Laboratory Procedures: Mechanistic Process and
Techniques. 14.Epigenomic Studies Perspective: Malignant Neoplasm,
Protastic Adenocarcinoma-Prostate Cancer CaP. 15.Pediatric Acute
Lymphoblastic Leukemia (ALL): Aberrant Epigenomic Modulation Surrogate.
16.Cardiovascular Disease (CVD) : DNA Methylation of Candidate Genes (ACE
II, IFN-¿, AGTR1, CKG, ADD1, SCNN1B and TLR2) in Essential Hypertension.
Medicine and Public Health. 1.Introductory Epigenomic Epidemiology: Basic
Concepts and Application. 2.Public Health, Epidemiology and Translational
Epigenomic Epidemiology Perspective. 3.Scientific Research Concept and
Application: Public Health, Clinical Medicine and Epigenomic Epidemiology
Studies. 4.Disease Ascertainment-Diagnostic and Screening Test.
5.Epigenomic Epidemiology: Disease Association, Etiology, Prognosis and
Outcomes. Part 2 Traditional and Modern Epidemiologic Designs 6.Measures of
Disease Occurrence and Effect or Association. 7.Ecologic Design.
8.Cross-Sectional Study Design (Non-experimental). 9.Case-Control
(Comparison/Non-Case) Design. 10.Cohort Designs: Prospective,
Retrospective, Ambi-directional. 11.Human Experimental Design-Clinical
Trials. 12.Epidemiologic Causal Inference: Causality Web, Meta-Analysis,
Quantitative Evidence Synthesis (QES). Part 3 Laboratory Techniques and
Epigenomic Mechanistic Process in Epidemiologic Principles, Concept and
Application. 13.Epigenomic Laboratory Procedures: Mechanistic Process and
Techniques. 14.Epigenomic Studies Perspective: Malignant Neoplasm,
Protastic Adenocarcinoma-Prostate Cancer CaP. 15.Pediatric Acute
Lymphoblastic Leukemia (ALL): Aberrant Epigenomic Modulation Surrogate.
16.Cardiovascular Disease (CVD) : DNA Methylation of Candidate Genes (ACE
II, IFN-¿, AGTR1, CKG, ADD1, SCNN1B and TLR2) in Essential Hypertension.
Part 1: Epidemiology and Epigenomic Epidemiology Contribution in Clinical
Medicine and Public Health. 1.Introductory Epigenomic Epidemiology: Basic
Concepts and Application. 2.Public Health, Epidemiology and Translational
Epigenomic Epidemiology Perspective. 3.Scientific Research Concept and
Application: Public Health, Clinical Medicine and Epigenomic Epidemiology
Studies. 4.Disease Ascertainment-Diagnostic and Screening Test.
5.Epigenomic Epidemiology: Disease Association, Etiology, Prognosis and
Outcomes. Part 2 Traditional and Modern Epidemiologic Designs 6.Measures of
Disease Occurrence and Effect or Association. 7.Ecologic Design.
8.Cross-Sectional Study Design (Non-experimental). 9.Case-Control
(Comparison/Non-Case) Design. 10.Cohort Designs: Prospective,
Retrospective, Ambi-directional. 11.Human Experimental Design-Clinical
Trials. 12.Epidemiologic Causal Inference: Causality Web, Meta-Analysis,
Quantitative Evidence Synthesis (QES). Part 3 Laboratory Techniques and
Epigenomic Mechanistic Process in Epidemiologic Principles, Concept and
Application. 13.Epigenomic Laboratory Procedures: Mechanistic Process and
Techniques. 14.Epigenomic Studies Perspective: Malignant Neoplasm,
Protastic Adenocarcinoma-Prostate Cancer CaP. 15.Pediatric Acute
Lymphoblastic Leukemia (ALL): Aberrant Epigenomic Modulation Surrogate.
16.Cardiovascular Disease (CVD) : DNA Methylation of Candidate Genes (ACE
II, IFN-¿, AGTR1, CKG, ADD1, SCNN1B and TLR2) in Essential Hypertension.
Medicine and Public Health. 1.Introductory Epigenomic Epidemiology: Basic
Concepts and Application. 2.Public Health, Epidemiology and Translational
Epigenomic Epidemiology Perspective. 3.Scientific Research Concept and
Application: Public Health, Clinical Medicine and Epigenomic Epidemiology
Studies. 4.Disease Ascertainment-Diagnostic and Screening Test.
5.Epigenomic Epidemiology: Disease Association, Etiology, Prognosis and
Outcomes. Part 2 Traditional and Modern Epidemiologic Designs 6.Measures of
Disease Occurrence and Effect or Association. 7.Ecologic Design.
8.Cross-Sectional Study Design (Non-experimental). 9.Case-Control
(Comparison/Non-Case) Design. 10.Cohort Designs: Prospective,
Retrospective, Ambi-directional. 11.Human Experimental Design-Clinical
Trials. 12.Epidemiologic Causal Inference: Causality Web, Meta-Analysis,
Quantitative Evidence Synthesis (QES). Part 3 Laboratory Techniques and
Epigenomic Mechanistic Process in Epidemiologic Principles, Concept and
Application. 13.Epigenomic Laboratory Procedures: Mechanistic Process and
Techniques. 14.Epigenomic Studies Perspective: Malignant Neoplasm,
Protastic Adenocarcinoma-Prostate Cancer CaP. 15.Pediatric Acute
Lymphoblastic Leukemia (ALL): Aberrant Epigenomic Modulation Surrogate.
16.Cardiovascular Disease (CVD) : DNA Methylation of Candidate Genes (ACE
II, IFN-¿, AGTR1, CKG, ADD1, SCNN1B and TLR2) in Essential Hypertension.